Bio-Rad Laboratories (NYSE:BIO.B) Releases Quarterly Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) released its quarterly earnings results on Thursday. The company reported $2.90 EPS for the quarter, Zacks reports. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Stock Performance

Bio-Rad Laboratories stock remained flat at $312.05 during trading hours on Monday. 42 shares of the company's stock traded hands, compared to its average volume of 112. The company has a market cap of $8.74 billion, a price-to-earnings ratio of -11.42 and a beta of 0.73. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. Bio-Rad Laboratories has a 12 month low of $279.91 and a 12 month high of $359.22. The business's 50-day simple moving average is $337.61 and its 200-day simple moving average is $333.43.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.